511 related articles for article (PubMed ID: 23478005)
21. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
[TBL] [Abstract][Full Text] [Related]
22. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
Muenst S; Hoeller S; Dirnhofer S; Tzankov A
Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
Gerber NK; Atoria CL; Elkin EB; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.
Martini M; Hohaus S; Petrucci G; Cenci T; Pierconti F; Massini G; Teofili L; Leone G; Larocca LM
Am J Clin Pathol; 2008 Mar; 129(3):472-7. PubMed ID: 18285272
[TBL] [Abstract][Full Text] [Related]
25. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
[TBL] [Abstract][Full Text] [Related]
26. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
Wang E; Papavassiliou P; Sebastian S
Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
[TBL] [Abstract][Full Text] [Related]
27. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of vitamin D receptor and forkhead box P3 in classic Hodgkin lymphoma: correlation with clinical and pathologic findings.
Gupta GK; Agrawal T; Pilichowska M
BMC Cancer; 2020 Jun; 20(1):535. PubMed ID: 32513132
[TBL] [Abstract][Full Text] [Related]
29. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases.
Quiñones-Avila Mdel P; Gonzalez-Longoria AA; Admirand JH; Medeiros LJ
Am J Clin Pathol; 2005 May; 123(5):651-6. PubMed ID: 15981804
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era.
Wang Q; Qin Y; Zhou S; He X; Yang J; Kang S; Liu P; Yang S; Zhang C; Gui L; Sun Y; Shi Y
Oncotarget; 2016 Nov; 7(44):72219-72228. PubMed ID: 27750215
[TBL] [Abstract][Full Text] [Related]
31. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
Kelley TW; Pohlman B; Elson P; Hsi ED
Am J Clin Pathol; 2007 Dec; 128(6):958-65. PubMed ID: 18024321
[TBL] [Abstract][Full Text] [Related]
32. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
Salama ME; Rajan Mariappan M; Inamdar K; Tripp SR; Perkins SL
Int J Surg Pathol; 2010 Apr; 18(2):121-8. PubMed ID: 19223373
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study.
Yang M; Ping L; Liu W; Xie Y; Aliya ; Liu Y; Nuersulitan R; Zhu J; Wu M; Song Y
Hematology; 2019 Dec; 24(1):413-419. PubMed ID: 30922173
[TBL] [Abstract][Full Text] [Related]
34. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
36. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
[TBL] [Abstract][Full Text] [Related]
37. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
[TBL] [Abstract][Full Text] [Related]
38. The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma.
Gupta S; Yeh S; Chami R; Punnett A; Chung C
Eur J Cancer; 2013 Oct; 49(15):3255-61. PubMed ID: 23791542
[TBL] [Abstract][Full Text] [Related]
39. Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.
Tsuyuki Y; Kohno K; Inagaki Y; Sakai Y; Kosugi H; Takahashi E; Suzuki Y; Shimada S; Kato S; Takahara T; Satou A; Shimoyama Y; Nakamura S; Asano N; Sakakibara A
J Clin Exp Hematop; 2021; 61(3):173-179. PubMed ID: 34511545
[TBL] [Abstract][Full Text] [Related]
40. Concurrent gastric MALT and Hodgkin lymphoma: a case report.
Oka K; Nagayama R; Yonekawa N; Nihei T; Sando N; Yatabe Y; Mori N
Int J Surg Pathol; 2012 Apr; 20(2):201-4. PubMed ID: 21813545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
